Peficitinib, a novel drug targeting this specific kinase, offers a significant advance in the management of rheumatoid arthritis . Early clinical studies indicate that it appears to demonstrably lessen https://peficitinib151765.pointblog.net/peficitinib-a-potential-solution-for-autoimmune-arthritis-96051227